Page 51 - GTM-2-3
P. 51

Global Translational Medicine                                           Deep learning by NMR-biochemical



            parameters and demand large data and uniform thresholds   to  establish  the  diagnostic  accuracy  of  hybrid  MRI
            of substantial hepatosteatosis limits.             approaches.
            6.7. Monitoring hepatocellular carcinoma and liver   6.11. Migraine pathophysiology and identification
            cirrhosis development                              of neuromarkers in migraine
            1 H‑MRI+MRS predicted the probability by high Cho, lipid   The   1 H-MRS studies suggested many inter-ictal
            (Lip) contents, and Cho/Lip ratio on LCModel software to   abnormalities in migraine patients with persistent
            assess the magnitude of hepatocellular carcinoma (HCC)   altered mitochondrial energy loss, neuronal excitability
            with secondary chronic hepatitis B and cirrhosis [108] . The   indicated by high excitatory glutamate, high inhibitory
            author suggests that  H-MRS-visible hepatic metabolite   GABA  neurotransmitter  peaks,  low  NAA  levels  due
                              1
            levels may monitor both HCC and liver cirrhosis    to  mitochondrial  dysfunction,  and  abnormal  energy
            development, but more validation studies are needed.  metabolism toward excitatory stimulation or migraine
                                                               attack triggers [113] . MRS can be a valuable non-invasive
            6.8. Low back pain                                 method to determine migraine attacks, correlate severity,
            In vivo  MRS  in  low  back  pain  subjects  showed:  (i)  low   and monitor medication efficacy.
            NAA concentration in the right primary motor cortex, left
            anterior insula, left somatosensory cortex (SSC), anterior   6.12. Adrenoleukodystrophy
            cingulate cortex (ACC), and dorsolateral prefrontal cortex   Status  epilepticus or  childhood cALD  shows  abrupt
            (DLPFC) regions; (ii) low glutamate in ACC; (iii) low MI in   pathogenic ABCD1 mutation or transiently altered mental
            ACC and thalamus; (iv) high choline in the right SSC; and   status neurodegeneration in autism with fever, diarrhea,
            (v) high glucose in the DLPFC locations [109] . Biochemical   seizures, coma, gross motor loss, fine motor loss, and
            alteration in low back pain-brain MRS profile correlates   poor speech skills. Serial brain MRI/MRS showed elevated
            with possible therapy response and the physiochemical   lactate peak and CSF protein levels associated with
            functions  of  brain  metabolites  and  pain  receptors.  The   diffused progressive cortex swelling, laminar necrosis,
            author notices concerns about the few subjects selected,   and  restricted  diffusion  indicative  of  mitochondrial,
            confounding factors, medication effects, and unclear   lysosomal, and peroxisomal disorders. Moreover, MRS
            biochemical basis of pain-specific metabolite changes.  showed elevated very-long-chain fatty acids, lactate peaks,
                                                               and high CSF proteins. The acute decline in neurologic
            6.9. Juvenile myoclonic epilepsy                   functions with elevated CSF proteins and lactate and acute
            1 H-MRS showed distinct low NAA and NAA/Cr ratio, a rise   decline in neurologic NAA/Cr functions by MRS indicates
            in Glx/Cr ratio in the insula and striatum to indicate juvenile   MRI non-visible white matter abnormalities to predict
            myoclonic epilepsy (JME) as multi-region, thalamo-frontal   disease progression [114] .
            network epilepsy (not idiopathic general epilepsy) [110] . The
            frontal cortex and thalamo-cortical pathways indicated low   6.13. Hypoxic-ischemic encephalopathy
            NAA and low NAA/Cr ratio in the frontal region of JME   Proton MRI with MRS showed elevated Lac/NAA ratio
            related  to  memory  and  visual  attention  Stroop  test;  low   in posterior white matter areas and deep gray nuclei of
            NAA/Cr ratio in thalamic linguistic and memory regional   putamen and thalamus areas as prognostic indicators
            Wisconsin card sorting test. Unaltered Glx, Glx/tCr ratio,   for  brain  hypoxic-ischemic  injury  underlying  neonatal
            Cho compounds, and Cho/tCr ratio in frontal and thalamic   hypoxic-ischemic encephalopathy (HIE) [115] . Proton
                                                                    1
            regions were associated with epileptic cortical functions,   MRS ( H-MRS) showed high NAA/tCr in basal ganglia/
            neuropsychological cognitive tests as visuospatial executive   thalamus(BG/T),  high  NAA/Cho  in  basal  ganglia/
            functions, linguistic, memory, and visual attention [111] . The   thalamus (BG/T), and high Myo‑inositol/choline in the
            MRS may show subclinical cognitive changes. The author   cerebral cortex as a prognostic marker of therapeutic
            suggests the need for validation studies.          hypothermia (TH) with adverse outcomes of white
                                                               matter and gray matter NAA in prediction for all HIE
            6.10. Primary focal CNS lymphoma lesions           subjects. The author suggests the need for prospective

            A hybrid approach of MRS with SPECT and PET        multi-center studies by standardized protocol and
            distinguished the CNS lymphoma from the human      analysis methods [116] .
            immunodeficiency virus (HIV) [112] . MR perfusion,
            MRI APC ratio, and regional cerebral blood volume   6.14. Traumatic brain injury
            characteristics distinguish lymphoma from HIV-infected   The single-voxel  H-MRS showed an altered ratio of NAA/
                                                                            1
            patients. The author suggests more clinical investigations   Cr+phosphocreatine (PCr), NAA+N-acetylaspartylglutamate

            Volume 2 Issue 3 (2023)                         19                        https://doi.org/10.36922/gtm.337
   46   47   48   49   50   51   52   53   54   55   56